herbalife

Herbalife Beats Estimates: All Eyes on the Conference Call

Herbalife Beats Estimates: All Eyes on the Conference Call

Herbalife Ltd. (NYSE:HLF) reported 4Q12 EPS of $1.05, $0.02 ahead of consensus; the pre-announced guidance range was $1.02-$1.05.  On a constant currency basis, EPS grew by 26% year-over-year. Total revenues rose by 19.8%, in line with the pre-announced forecast but ahead of the original guidance of +17%-19%.  Sales growth was strong and broad based, with all six geographic regions posting double-digit increases in local currency.  Volume Points grew by 18.4%, also consistent with pre-announced guidance.  The strongest geographic region was South/Central America at +34.0%.

Gross margins for Herbalife Ltd. (NYSE:HLF) declined by 60 bp, about in line with forecasts for a 50 bp decline, with most of the decline related to foreign currency fluctuations. Royalties as a percentage of sales increased by 44 bp, while SG&A expenses as a percentage of sales decreased by 94 bp, with part of these fluctuations due to a reclassification of an item from SG&A into royalties. In aggregate, the operating margin declined by 28 bp, in line with consensus.  The tax rate was slightly higher than forecast but this was offset by a slightly lower-than-expected share count.

 

Herbalife Ltd. (NYSE:HLF) also filed its 10k SEC filing, which is notable because it was audited by KPMG.  KPMG expressed an unqualified opinion on the effectiveness of Herbalife’s internal controls over financial reporting. Given the increased scrutiny related to Herbalife, some investors (such as Bill Ackman) were concerned KPMG may not sign off on the financials. Additionally, in the 10k, Herbalife disclosed that it requested a meeting with the SEC’s Division of Enforcement in response to Pershing Square’s presentation on December 20, 2012.  The SEC staff is looking into the market events around that event and Herbalife is fully cooperating with this investigation by providing information related to the company’s business and financial operations.

 

Guidance

Herbalife raised its FY13 guidance and provided initial 1Q13 guidance.  The new FY13 guidance included: volume point growth of 8.5%-10.5% (unchanged from prior guidance), total sales growth of 12.0%-14.0% (vs. 10%-12% prior), and EPS of $4.45-$4.65 (vs. $4.40-$4.55 prior).  The initial 1Q13 guidance consisted of volume point growth of 11.5%-13.5%, total sales growth of 15.0%-17.0%, and EPS of $1.03-$1.07 (vs. consensus estimates at $1.06). The guidance includes the $162 million of share repurchases completed 1Q-to-date, as well as assumes an additional $50 million of share repurchases per quarter for 2Q-4Q.  The guidance excludes $10-$20 million of non-recurring legal and advisory expenses related to defending itself from Bill Ackman/Pershing Square’s accusations.

What Investors expect from the stock

Investors expect the stock to trade higher tomorrow, although Herbalife is down slightly in post market trading.  The results for 4Q12 were already pr eannounced so there wasn’t much of a surprise there. Bullish guidance for 1Q13 and an increase to FY13 guidance likely indicates that the negative publicity that Bill Ackman’s Pershing Square is creating might not be having a significant impact on actual results, at least at this point. Additionally, the fact that KPMG signed off on the 2012 financial results may ease the concerns of some investors (Bill Ackman cited KPMG not stamping its approval for Herbalife as a possibility at recent conference).

 

Conference Call Details

Conference call tomorrow at 11 AM EST. All eyes will be on the conference call and what the company says.

LEAVE A COMMENT


X
Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

What’s missing today for many investors is real, straightforward advice.

Especially when it comes to Value Investing and Hedge Funds. 💵

That’s what makes ValueWalk Premium different. Some would say we’re “unusual.”

Our subscribers look forward to clear, easy-to-understand information they can act on.

Sign up for  today for only a few dollars a day and get a 3 day no obligation trial with a targeted 20% discount coupon code.

Cancel anytime during trial and you are never charged.

Limited time offer: For first 50 subscribers

0